Avidity Biosciences launches $500M proposed public offering

2 hours ago 1

Avidity Biosciences (NASDAQ:RNA) intends to offer and sell $500.0 million of shares of its common stock in an underwritten public offering.
Avidity intends to use the net proceeds from this offering, together with its existing cash, cash equivalents and marketable securities, to advance